Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes

Journal of Virology

Volumn 81, Issue 11, 2007, Pages 5919-5928

  Campbell, Grant R ^a   Watkins, Jennifer D ^b   Singh, Kumud K ^a   Loret, Erwann P ^b   Spector, Stephen A ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b CNRS   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR; CYSTEINE; MONOCYTE CHEMOTACTIC PROTEIN 1; REGULATOR PROTEIN; SERINE; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL FUNCTION; CELL MEMBRANE; CYTOKINE PRODUCTION; EPIDEMIOLOGICAL DATA; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; VIRUS STRAIN;

CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; GENE PRODUCTS, TAT; HELA CELLS; HIV-1; HUMANS; INTRACELLULAR FLUID; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34249815238     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01938-06     Document Type: Article

References (93)

1. Adle-Biassette, H., F. Chretien, L. Wingertsmann, C. Héry, T. Ereau, F. Scaravilli, M. Tardieu, and F. Gray. 1999. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol. Appl. Neurobiol. 25:23-133.
2. Albini, A., R. Benelli, D. Giunciuglio, T. Cai, G. Mariani, S. Ferrini, and D. M. Noonan. 1998. Identification of a novel domain of HIV Tat involved in monocyte chemotaxis. J. Biol. Chem. 273:15895-15900.
3. Albini, A., S. Ferrini, R. Benelli, S. Sforzini, D. Giunciuglio, M. G. Aluigi, A. E. Proudfoot, S. Alouani, T. N. Wells, G. Mariani, R. L. Rabin, J. M. Farber, and D. M. Noonan. 1998. HIV-1 Tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. USA 95:13153-13158.
4. Aquaro, S., S. Panti, M. C. Caroleo, E. Balestra, A. Cenci, F. Forbici, G. Ippolito, A. Mastino, R. Testi, V. Mollace, R. Calio, and C. F. Perno. 2000. Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes. J. Leukoc. Biol. 68:429-435.
5. Arya, S. K., B. Beaver, L. Jagodzinski, B. Ensoli, P. J. Kanki, J. Albert, E. M. Fenyo, G. Biberfeld, J. F. Zagury, F. Laure, M. Essex, E. Norby, F. Wong-Staal, and R. C. Gallo. 1987. New human and simian HIV-related retroviruses possess functional transactivator (tat) gene. Nature 328:548-550.
6. Badou, A., Y. Bennasser, M. Moreau, C. Leclerc, M. Benkirane, and E. Bahraoui. 2000. Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway. J. Virol. 74:10551-10562.
7. Banks, W. A., S. M. Robinson, and A. Nath. 2005. Permeability of the blood-brain barrier to HIV-1 Tat. Exp. Neurol. 193:218-227.
8. Barany, G., and R. B. Merrifield. 1980. Solid phase peptide synthesis, p. 1-284. In E. Gross and J. Meinhofer (ed.), The peptide: analysis, synthesis, biology, vol. 2. Academic Press, New York, NY.
9. Barillari, G., R. Gendelman, R. C. Gallo, and B. Ensoli. 1993. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90:7941-7945.
10. Barillari, G., C. Sgadari, V. Fiorelli, F. Samaniego, S. Colombini, V. Manzari, A. Modesti, B. C. Nair, A. Cafaro, M. Sturzl, and B. Ensoli. 1999. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 94:663-672.
11. Benelli, R., R. Mortarini, A. Anichini, D. Giunciuglio, D. M. Noonan, S. Montalti, C. Tacchetti, and A. Albini. 1998. Monocyte-derived dendritic cells and monocytes migrate to HIV-Tat RGD and basic peptides. AIDS 12:261-268.
12. Benveniste, E. N., V. T. Nguyen, and D. R. Wesemann. 2004. Molecular recognition of CD40 expression in macrophages and microglia. Brain Behav. Immun. 18:7-12.
13. Berridge, M. J. 1993. Inositol trisphosphate and calcium signalling. Nature 361:315-325.
14. Bhoopat, L., T. S. Rithaporn, S. Khunamornpong, T. Bhoopat, C. R. Taylor, and P. S. Thorner. 2006. Cell reservoirs in lymph nodes infected with HIV-1 subtype E differ from subtype B: identification by combined in situ polymerase chain reaction and immunohistochemistry. Mod. Pathol. 19:255-263.
15. Brabers, N. A., and H. S. Nottet. 2006. Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur. J. Clin. Investig. 36:447-458.
16. Brack-Werner, R. 1999. Astrocytes. HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 13:1-22.
17. Campbell, G. R., E. Pasquier, J. Watkins, V. Bourgarel-Rey, V. Peyrot, D. Esquieu, P. Barbier, J. de Mareuil, D. Braguer, P. Kaleebu, D. L. Yirrell, and E. P. Loret. 2004. The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. J. Biol. Chem. 279:48197-48204.
18. Campbell, G. R., J. D. Watkins, D. Esquieu, E. Pasquier, E. P. Loret, and S. A. Spector. 2005. The C-terminus of HIV-1 Tat modulates the extent of CD178 mediated apoptosis of T cells. J. Biol. Chem. 280:38376-38382.
19. Capini, C. J., M. W. Richardson, H. Hendel, A. Sverstiuk, J. Mirchandani, E. G. Régulier, K. Khalili, J. F. Zagury, and J. Rappaport. 2001. Autoantibodies to TNFalpha in HIV-1 infection: prospects for anti-cytokine vaccine therapy. Biomed. Pharmacother. 5:23-31.
20. Carnevale, K. A., and M. K. Cathcart. 2003. Protein kinase C beta is required for human monocyte chemotaxis to MCP-1. J. Biol. Chem. 278:25317-25322.
21. Chang, H. C., F. Samaniego, B. C. Nair, L. Buonaguro, and B. Ensoli. 1997. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 11:1421-1431.
22. Clouse, K. A., L. M. Cosentino, K. A. Weih, S. W. Pyle, P. B. Robbins, H. D. Hochstein, V. Natarajan, and W. L. Farrar. 1991. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J. Immunol. 147:2892-2901.
23. Colotta, F., A. Borre, J. M. Wang, M. Tattanelli, F. Maddalena, N. Polentarutti, G. Peri, and A. Mantovani. 1992. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J. Immunol. 148:760-765.
24. Contreras, X., Y. Bennasser, N. Chazal, and E. Bahraoui. 2003. HIV-1 Tat induces TNF-alpha production by human monocytes: involvement of calcium and PKC pathways. J. Soc. Biol. 197:267-275.
25. Contreras, X., Y. Bennasser, N. Chazal, M. Moreau, C. Leclerc, J. Tkaczuk, and E. Bahraoui. 2005. Human immunodeficiency virus type 1 Tat protein induces an intracellular calcium increase in human monocytes that requires DHP receptors: involvement in TNF-alpha production. Virology 332:316-328.
26. D'Aversa, T. G., E. A. Eugenin, and J. W. Berman. 2005. NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation. J. Neurosci. Res. 81:436-446.
27. de Mareuil, J., M. Carre, P. Barbier, G. R. Campbell, S. Lancelot, S. Opi, D. Esquieu, J. D. Watkins, C. Prevot, D. Braguer, V. Peyrot, and E. P. Loret. 2005. HIV-1 Tat protein enhances microtubule polymerization. Retrovirology 2:5.
28. Desfosses, Y., M. Solis, Q. Sun, N. Grandvaux, C. Van Lint, A. Bumy, A. Gatignol, M. A. Wainberg, R. Lin, and J. Hiscott. 2005. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins. J. Virol. 79:9180-9191.
29. Elovaara, I., F. Sabri, F. Gray, I. Alafuzoff, and F. Chiodi. 1999. Upregulated expression of Fas and Fas ligand in brain through the spectrum of HIV-1 infection. Acta Neuropathol. (Berlin) 98:355-362.
30. Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield, and R. C. Gallo. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:277-287.
31. Fiala, M., D. J. Looney, M. Stins, D. D. Way, L. Zhang, X. Gan, F. Chiappelli, E. S. Schweitzer, P. Shapshak, M. Weinand, M. C. Graves, M. Witte, and K. S. Kim. 1997. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol. Med. 3:553-564.
32. Giulian, D., J. Li, S. Bartel, J. Broker, X. Li, and J. B. Kirkpatrick. 1995. Cell surface morphology identifies microglia as a distinct class of mononuclear phagocyte. J. Neurosci. 15:7712-7726.
33. Glass, J., H. Fedor, S. Wesselingh, and J. McArthur. 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38:755-762.
34. Grant, I., N. Sacktor, and J. McArthur. 2005. HIV neurocognitive disorders, p. 357-373. In H. E. Gendelman, I. Grant, I. Everall, S. A. Lipton, and S. Swindells (ed.), The neurology of AIDS, 2nd ed. Oxford University Press, London, United Kingdom.
35. Gray, F., H. Adle-Biassette, F. Chretien, G. Lorin de la Grandmaison, G. Force, and C. Keohane. 2001. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin. Neuropathol. 20:146-155.
36. Griffin, D. E. 1997. Cytokines in the brain during viral infection: clues to HIV-associated dementia. J. Clin. Investig. 100:2948-2951.
37. Gui, P., X. Wu, S. Ling, S. C. Stotz, R. J. Winkfein, E. Wilson, G. E. Davis, A. P. Braun, G. W. Zamponi, and M. J. Davis. 2006. Integrin receptor activation triggers converging regulation of Cav1.2 calcium channels by c-Src and protein kinase A pathways. J. Biol. Chem. 281:14015-14025.
38. Hemelaar, J., E. Gouws, P. D. Ghys, and S. Osmanov. 2006. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20:W13-W23.
39. Heyes, M. P., B. J. Brew, A. Martin, R. W. Price, A. M. Salazar, J. J. Sidtis, J. A. Yergey, M. M. Mouradian, A. E. Sadler, J. Keilp, D. Rubinow, and S. P. Markey. 1991. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:202-209.
40. Hira, S. K., G. J. Dore, and T. Sirisanthana. 1998. Clinical spectrum of HIV/AIDS in the Asia-Pacific region. AIDS 12(Suppl. B):S145-S154.
41. Hofman, F. M., M. M. Dohadwale, A. D. Wright, D. R. Hinton, and S. M. Walker. 1994. Exogenous tat protein activates central nervous system-derived endothelial cells. J. Neuroimmunol. 54:19-28.
42. Hudson, L., J. Liu, A. Nath, M. Jones, R. Raghavan, O. Narayan, D. Male, and I. Everall. 2000. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J. Neurovirol. 6:145-155.
43. Huigen, M. C., W. Kamp, and H. S. Nottet. 2004. Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection. Eur. J. Clin. Investig. 34:57-66.
44. Jeang, K. T., H. Xiao, and E. A. Rich. 1999. Muitifaceted activities of the HIV-1 transactivator of transcription, Tat. J. Biol. Chem. 274:28837-28840.
45. Jiang, Y., D. I. Beller, G. Frendl, and D. T. Graves. 1992. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J. Immunol. 148:2423-2428.
46. Jones, M., K. Olafson, M. R. Del Bigio, J. Peeling, and A. Nath. 1998. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J. Neuropathol. Exp. Neurol. 57:563-570.
47. Kaleebu, P., A. Ross, D. Morgan, D. Yirrell, J. Oram, A. Rutebemberwa, F. Lyagoba, L. Hamilton, B. Biryahwaho, and J. Whitworth. 2001. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS 15:293-299.
48. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66:2232-2239.
49. King, J. E., E. A. Eugenin, C. M. Buckner, and J. W. Berman. 2006. HIV tat and neurotoxicity. Microbes Infect. 8:1347-1357.
50. Lafrenie, R. M., L. M. Wahl, J. S. Epstein, I. K. Hewlett, K. M. Yamada, and S. Dhawan. 1996. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. J. Immunol. 157:974-977.
51. Lole, K. S., R. C. Bollinger, R. S. Paranjape, D. Gadkari, S. S. Kulkarni, N. G. Novak, R. Ingersoll, H. W. Sheppard, and S. C. Ray. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73:152-160.
52. Minghetti, L., S. Visentin, M. Patrzio, L. Franchini, M. A. Ajmone-Cat, and G. Levi. 2004. Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions. Neurochem. Res. 29:965-978.
53. Mörner, A., A. Bjorndal, V. KewalRamani, D. R. Littman, R. Inoue, R. Thorstensson, E. M. Fenyo, and E. Bjorling. 1999. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J. Virol. 73:2343-2349.
54. Nath, A., J. D. Geiger, M. P. Mattson, D. S. K. Magnuson, M. Jones, and J. R. Berger. 1998. Role of viral proteins in HIV-1 neuropathogenesis with emphasis on Tat. NeuroAIDS 1:6. http://aidscience.com/neuroaids/articles/ Neuro1(6).asp.
55. Nath, A., K. Conant, P. Chen, C. Scott, and E. O. Major. 1999. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J. Biol. Chem. 274:17098-17102.
56. Nicholls, D., and D. Attwell. 1990. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 11:462-468.
57. Opi, S., J. M. Peloponese, Jr., D. Esquieu, G. Campbell, J. de Mareuil, A. Walburger, M. Solomiac, C. Gregoire, E. Bouveret, D. L. Yirrell, and E. P. Loret. 2002. Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants. J. Biol. Chem. 277:35915-35919.
58. Opi, S., J. M. Peloponese, Jr., D. Esquieu, J. Watkins, G. Campbell, J. de Mareuil, K. T. Jeang, D. L. Yirrell, P. Kaleebu, and E. P. Loret. 2004. Full-length HIV-1 Tat protein necessary for a vaccine. Vaccine 22:3105-3111.
59. Park, I. W., J. F. Wang, and J. E. Groopman. 2001. HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. Blood 97:352-358.
60. Partida-Sánchez, S., S. Goodrich, K. Kusser, N. Oppenheimer, T. D. Randall, and F. E. Lund. 2004. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity 20:279-291.
61. 2+ responses and chemotaxis in cultured human vascular smooth muscle cells. Br. J. Pharmacol. 145:811-817.
62. Péloponèse, J. M., Jr., Y. Collette, C. Grègoire, C. Bailly, D. Campèse, E. F. Meurs, D. Olive, and E. P. Loret. 1999. Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents. J. Biol. Chem. 274:11473-11478.
63. Perry, S. W., S. Dewhurst, M. J. Bellizzi, and H. A. Gelbard. 2002. Tumor necrosis factor-alpha in normal and diseased brain: conflicting effects via intraneuronal receptor crosstalk? J. Neurovirol. 8:611-624.
64. Pu, H., J. Tian, G. Flora, Y. W. Lee, A Nath, B. Hennig, and M. Toborek. 2003. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol. Cell. Neurosci. 24:224-237.
65. Ramalingam, S., R. Kannangai, T. S. Vijayakumar, D. Mathai, O. C. Abraham, S. Subramanian, P. Rupali, M. V. Jesudason, and G. Sridharan. 2005. Subtype and cytokine profiles of HIV infected individuals from south India. Indian J. Med. Res. 121:226-234.
66. Ranga, U., R. Shankarappa, N. B. Siddappa, L. Ramakrishna, R. Nagendran, M. Mahalingam, A. Mahadevan, N. Jayasuryan, P. Satishchandra, S. K. Shankar, and V. R. Prasad. 2004. Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J. Virol. 78:2586-2590.
67. Ranjbar, S., R. Rajsbaum, and A. E. Goldfeld. 2006. Transactivator of transcription from HIV type 1 subtype E selectively inhibits TNF gene expression via interference with chromatin remodeling of the TNF locus. J. Immunol. 176:4182-4190.
68. Rappaport, J., J. Joseph, S. Croul, G. Alexander, L. Del Valle, S. Amini, and K. Khalili. 1999. Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J. Leukoc. Biol. 65:458-465.
69. Sabri, F., A. De Milito, R. Pirskanen, I. Elovaara, L. Hagberg, P. Cinque, R. Price, and F. Chiodi. 2001. Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex. J. Neuroimmunol. 114:197-206.
70. Saha, R. N., and K. Pahan. 2003. Tumor necrosis factor-alpha at the cross-roads of neuronal life and death during HIV-associated dementia. J. Neurochem. 86:1057-1071.
71. Sahni, A. K., V. V. Prasad, and P. Seth. 2002. Genomic diversity of human immunodeficiency virus type-1 in India. Int. J. STD AIDS 13:115-118.
72. Satishchandra, P., A. Nalini, M. Gourie-Devi, N. Khanna, V. Santosh, V. Ravi, A. Desai, A. Chandramuki, P. N. Jayakumar, and S. K. Shankar. 2000. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian J. Med. Res. 111:14-23.
73. Sengupta, S., S. Jana, K. Sarkar, S. K. Bhattacharya, and S. Chakrabarti. 2005. Determination of gag subtypes of HIV type 1 detected among female sex workers in Calcutta, India. AIDS Res. Hum. Retrovir. 21:806-809.
74. Senkaali, D., R. Muwonge, D. Morgan, D. Yirrell, J. Whitworth, and P. Kaleebu. 2004. The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort. AIDS Res. Hum. Retrovir. 20:932-937.
75. Shankar, S. K., A. Mahadevan, P. Satishchandra, R. U. Kumar, T. C. Yasha, V. Santosh, A. Chandramuki, V. Ravi, and A. Nath. 2005. Neuropathology of HIV/AIDS with an overview of the Indian scene. Indian J. Med. Res. 121:468-488.
76. Siddappa, N. B., M. Venkatramanan, P. Venkatesh, M. V. Janki, N. Jayasuryan, A. Desai, V. Ravi, and U. Ranga. 2006. Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein. Retrovirology 3:53.
77. Smith, D. G., G. J. Guillemin, L. Pemberton, S. Kerr, A. Nath, G. A. Smythe, and B. J. Brew. 2001. Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. J. Neurovirol. 7:56-60.
78. Sporer, B., U. Koedel, F. D. Goebel, and H. W. Pfister. 2000. Increased levels of soluble Fas receptor and Fas ligand in the cerebrospinal fluid of HIV-infected patients. AIDS Res. Hum. Retrovir. 16:221-226.
79. Stone, T. W. 1993. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45:309-379.
80. Suh, G. H., and A. Shah. 2001. A review of the epidemiological transition in dementia-cross-national comparisons of the indices related to Alzheimer's disease and vascular dementia. Acta Psychiatr. Scand. 104:4-11.
81. Tardieu, M., C. Hery, S. Peudenier, O. Boespflug, and L. Montagnier. 1992. Human immunodeficiency virus type 1-infected monocytic cells can destroy Human neural cells after cell-to-cell adhesion. Ann. Neurol. 32:11-17.
82. Thompson, K. A., J. C. McArthur, and S. L. Wesselingh. 2001. Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann. Neurol. 49:745-752.
83. Towfighi, A., R. L. Skolasky, C. St. Hillaire, K. Conant, and J. C. McArthur. 2004. CSF soluble Fas correlates with the severity of HIV-associated dementia. Neurology 62:654-656.
84. Valle, L. D., S. Croul, S. Morgello, S. Amini, J. Rappaport, and K. Khalili. 2000. Detection of HIV-1 Tat and ICV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J. Neurovirol. 6:221-228.
85. Vasan, A., B. Renjifo, E. Hertzmark, B. Chaplin, G. Msamanga, M. Essex, W. Fawzi, and D. Hunter. 2006. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin. Infect. Dis. 42:843-852.
86. Wadia, R. S., S. N. Pujari, S. Kothari, M. Udhar, S. Kulkarni, S. Bhagat, and A. Nanivadekar. 2001. Neurological manifestations of HIV disease. J. Assoc. Physicians India 49:343-348.
87. Weiss, J. M., A. Nath, E. O. Major, and J. W. Berman. 1999. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J. Immunol. 163:2953-2959.
88. Weissman, D., R. L. Rabin, J. Arthos, A. Rubbert, M. Dybul, R. Swofford, S. Venkatesan, J. M. Farber, and A. S. Fauci. 1997. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389:981-985.
89. Wesselingh, S. L., C. Power, J. D. Glass, W. R. Tyor, J. McArthur, J. M. Farber, J. W. Griffin, and D. E. Griffin. 1993. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33:576-582.
90. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Strieker, J. Dhein, H. Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497-500.
91. Wiley, C. A., M. Baldwin, and C. L. Achim. 1996. Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10:843-847.
92. Xiao, H., C. Neuveut, H. L. Tiffany, M. Benkirane, E. A. Rich, P. M. Murphy, and K. T. Jeang. 2000. Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc. Natl. Acad. Sci. USA 97:11466-11471.
93. Zink, M. C., K. Suryanarayana, J. L. Mankowski, A. Shen, M. Piatak, Jr., J. P. Spelman, D. L. Carter, R. J. Adams, J. D. Lifson, and J. E. Clements. 1999. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J. Virol. 73:10480-10488.